Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-01-27
1989-04-18
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546119, C07D47104, A61K 31395
Patent
active
048227994
ABSTRACT:
Compounds of the formula ##STR1## and processes for and intermediates in the synthesis thereof, pharmaceutical compositions comprising such a compound and the use of such compounds for inhibiting cholesterol biosynthesis and lowering the blood cholesterol level and, therefore, in the treatment of hyperlipoproteinemia and atherosclerosis.
REFERENCES:
patent: 4248889 (1981-02-01), Oka et al.
patent: 4255444 (1981-03-01), Oka et al.
patent: 4293496 (1981-10-01), Willard
patent: 4459422 (1984-07-01), Willard et al.
patent: 4479965 (1984-10-01), Terahara et al.
patent: 4571428 (1986-02-01), Kapa
patent: 4588715 (1986-05-01), Damon
patent: 4613610 (1986-09-01), Wareing
patent: 4647576 (1987-03-01), Hoefle et al.
patent: 4751235 (1988-06-01), Anderson
patent: 4755606 (1988-07-01), Wareing
Hulcher, Arch. Biochem. Biophys. 146, 422-427 (1971).
Sato et al., Chem. Pharm. Bull. (Tokyo) 28, 1509-1525 (1980).
Singer et al., Proc. Soc. Exp. Biol. Med. 102, 370-373 (1959).
Kassenoff Melvyn M.
Lee Mary C.
Russell John A. H.
Sandoz Pharm. Corp.
Sharkin Gerald D.
LandOfFree
Pyrazolopyridine analogs of mevalonolactone and derivatives ther does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrazolopyridine analogs of mevalonolactone and derivatives ther, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazolopyridine analogs of mevalonolactone and derivatives ther will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2397129